Literature DB >> 6981182

The absence of circulating immune complexes in patients with ankylosing spondylitis.

W Maksymowych, M K Dasgupta, R S Rothwell, J B Dossetor, A S Russell.   

Abstract

Sera from 50 patients with well-defined ankylosing spondylitis were examined for circulating immune complexes using both a Clq binding (fluid phase) assay and a Raji cell assay. No more than five of the patients assessed had circulating immune complexes by either one of these techniques and none were positive in both. This result is in contrast to the high prevalence in sera from unselected patients with rheumatoid arthritis and systemic lupus used as positive controls.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6981182     DOI: 10.1007/BF00541253

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.

Authors:  T D Kinsella; L Espinoza; F B Vasey
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

2.  Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins.

Authors:  A A Eghtedari; P Davis; P A Bacon
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

3.  Complement metabolism in the seronegative arthritides.

Authors:  K Whaley; B Canesi; A Moseley; W Morrow; R Sturrock; W Mitchell; W C Dick
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

4.  Antiglobulin factors in sera from patients with rheumatoid arthritis and normal subjects. Quantitative estimation in different immunoglobulin classes.

Authors:  G Torrigiani; I M Roitt
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

5.  Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis.

Authors:  J T Rosenbaum; A N Theofilopoulos; H O McDevitt; A B Pereira; D Carson; A Calin
Journal:  Clin Immunol Immunopathol       Date:  1981-02

6.  Serum IgG, IgM, and IgA levels in ankylosing spondylitis.

Authors:  E M Veys; M van Leare
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

7.  Antiglobulins in ankylosing spondylitis.

Authors:  R M Arana; M T de la Vega; A Porrini; O Garcia Morteo
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

8.  Synovial inflammatory cell reaction in chronic arthritis.

Authors:  H Julkunen
Journal:  Acta Rheumatol Scand       Date:  1966

9.  Three polyethylene glycol dependent methods for the detection or circulating immune complexes in pathological sera: comparison with the Raji cell method.

Authors:  K V Johny; M K Dasgupta; S Nakashima; J B Dossetor
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

10.  Immune complexes and complement catabolism in ankylosing spondylitis.

Authors:  R Gabay; R H Zubler; U E Nydegger; P H Lambert
Journal:  Arthritis Rheum       Date:  1977-05
View more
  2 in total

1.  Immune complexes in ankylosing spondylitis.

Authors:  I L MacLean; J R Archer; M I Cawley; B L Kidd; B P O'Hara; F S Pegley; P W Thompson
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

2.  Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes.

Authors:  A J Peeters; A W van den Wall Bake; A D van Dalsen; M L Westedt
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.